Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Emergent Biosolutions (NY: EBS ) 9.950 +0.650 (+6.99%) Streaming Delayed Price Updated: 1:28 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Emergent Biosolutions < Previous 1 2 3 4 5 6 7 8 9 Next > Emergent Secures Contract To Manufacture Providence Therapeutics' COVID-19 Vaccine Candidate September 14, 2021 Emergent BioSolutions Inc (NYSE: EBS) has signed a five-year agreement with Providence Therapeutics valued at about $90 million to develop and... Via Benzinga Exposures COVID-19 Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns August 26, 2021 More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia... Via Benzinga Exposures COVID-19 Emergent BioSolutions' COVID-19 Plasma Candidate To Be Tested As Outpatient Treatment August 25, 2021 Emergent BioSolutions Inc (NYSE: EBS) has announced the initiation of a Phase 3 trial that will evaluate its investigational SARS-CoV-2 Immune Globulin Intravenous... Via Benzinga Exposures COVID-19 Emergent BioSolutions inc (EBS) Q2 2021 Earnings Call Transcript July 30, 2021 EBS earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant July 29, 2021 Emergent BioSolutions Inc (NYSE: EBS) will resume production of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine at its troubled Baltimore... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs July 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More July 25, 2021 Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... Via Benzinga Exposures Product Safety These Companies Have Seen Large Returns From 2020 Government Investment July 23, 2021 Much focus on investment comes from the private sector, particularly those of the venture capitalist persuasion. But one of the biggest investors this country has is the federal... Via Benzinga FDA Releases More JNJ's COVID-19 Vaccine Substance From Baltimore Plant July 06, 2021 Federal regulators on Friday Via Benzinga Exposures COVID-19 Product Safety Can Emergent BioSolutions Recover From Its Recent Blunders? July 03, 2021 Yes, but it probably won't be an easy path. Via The Motley Fool Exposures COVID-19 Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested June 29, 2021 Moderna Inc (NASDAQ: MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine. The COVID-... Via Benzinga Exposures COVID-19 A Look Into Healthcare Sector Value Stocks June 28, 2021 What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector June 21, 2021 A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... Via Benzinga FDA Authorizes 10M JNJ COVID-19 Vaccine Doses, Asks To Discard 60M From Emergent Plant: NYT June 11, 2021 The FDA has asked Johnson & Johnson (NYSE: JNJ) to discard 60 million doses of its COVID-19 vaccine manufactured at the troubled Emergent BioSolutions Inc... Via Benzinga Exposures COVID-19 Product Safety AstraZeneca Seeks Switching COVID-19 Vaccine Production to Catalent Plant: NYT June 03, 2021 AstraZeneca Plc (NASDAQ: AZN) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Emergent BioSolutions Inc’s (... Via Benzinga Exposures COVID-19 Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJ May 28, 2021 The FDA and Johnson & Johnson (NYSE: JNJ) are expected to announce that contamination problems at Emergent BioSolutions Inc’s (NYSE: EBS) Baltimore... Via Benzinga Exposures COVID-19 Product Safety 12 Health Care Stocks Moving In Friday's Pre-Market Session May 28, 2021 Gainers Iterum Therapeutics (NASDAQ:ITRM) shares moved upwards by 21.13% to $1.49 during Friday's pre-market session. The company's market cap stands at $266.9... Via Benzinga Justice Department Opens Probe In Presumed lapses at Eli Lilly's COVID-19 Drug Plant: Reuters May 27, 2021 The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (NYSE: LLY) focused on alleged manufacturing irregularities and records... Via Benzinga Exposures COVID-19 Emergent BioSolutions's Single-Dose Chikungunya Vaccine Candidate Effective Even After Two Years of Vaccination May 26, 2021 Emergent BioSolutions Inc (NYSE: EBS) has announced two-year persistence data from its Phase 2 study evaluating its investigational chikungunya virus, virus-like... Via Benzinga Emergent BioSolutions Stock Falls As Executives Face Questions As Part Of Botched Vaccine Probe May 19, 2021 The House Select Subcommittee on the Coronavirus announced last month that they were opening an investigation into Emergent BioSolutions Inc (NYSE: EBS), with... Via Benzinga Exposures COVID-19 Cramer Weighs In On Beyond Meat, Snowflake, More May 18, 2021 Jim Cramer said on CNBC's "Mad Money Lightning Round" he would buy more shares of Anthem Inc (NYSE: ANTM). He also likes UnitedHealth Group Inc (NYSE: UNH) and... Via Benzinga Emergent Initiates Quality Enhancement Plan For Troubled Baltimore Vaccine Facility May 12, 2021 Emergent BioSolutions Inc (NYSE: EBS) has been in headlines after its Baltimore plant has drawn the scrutiny of the FDA. A manufacturing mix-up ruined 15 million... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron May 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... Via Benzinga Exposures COVID-19 FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic May 10, 2021 The FDA has published a roadmap for working through the backlog of facility inspections built up during the pandemic when it postponed all routine inspections in March... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2021 May 05, 2021 Upgrades Atlantic Equities upgraded the previous rating for Under Armour Inc (NYSE:UAA) from Underweight to Neutral. Under Armour earned $0.16 in the first quarter. The... Via Benzinga Why Emergent BioSolutions Stock Dropped 30% in April May 04, 2021 The company went from hero to zero in the fight against COVID-19. Via The Motley Fool Exposures COVID-19 The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Is Emergent BioSolutions Still a Buy After Its Coronavirus Vaccine Flub? May 04, 2021 Shareholders beware: The hits just won't stop coming. Via The Motley Fool Exposures COVID-19 Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg April 30, 2021 Emergent BioSolutions Inc has manufactured over 115 million doses of the drug substance used in the Johnson & Johnson COVID-19 vaccine, 60 million doses of which are in vials and ready to deploy at... Via Talk Markets Exposures COVID-19 < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
